GL Biochem (Shanghai): difference between revisions
Diff·revision 29 → 30·10:03, 12 Nov 2024
Difference between revision 29 and revision 30 of GL Biochem (Shanghai). 2 lines changed; the page grew by 244 bytes.
| Revision 29 — 23:02, 6 Nov 2024 LedgerLysander (talk) add {{refimprove}}7,113 bytes +29 | Revision 30 — 10:03, 12 Nov 2024 BiosimilarBoaz (talk) ce 7,357 bytes +244 | ||
|---|---|---|---|
| 44 | | Catalogue peptides | Reference and research sequences | Lot certificate | | 44 | | Catalogue peptides | Reference and research sequences | Lot certificate | |
| 45 | 45 | ||
| + | 46 | The presence of amino acid derivatives, resins and coupling reagents in the catalogue is what most clearly places the organisation upstream: those are what a synthesis laboratory buys, not what a research-compound purchaser buys.{{r|selfpub}} | |
| + | 47 | ||
| 46 | == References == | 48 | == References == |
| 47 | {{reflist}} | 49 | {{reflist}} |